Authors
Alisha Jamal, Yaron Finkelstein, Nathan Kuppermann, Stephen B Freedman, Todd A Florin, Franz E Babl, Stuart R Dalziel, Roger Zemek, Amy C Plint, Dale W Steele, David Schnadower, David W Johnson, Derek Stephens, Anupam Kharbanda, Damian Roland, Mark D Lyttle, Charles G Macias, Ricardo M Fernandes, Javier Benito, Suzanne Schuh
Publication date
2019/8/1
Journal
The Lancet Child & Adolescent Health
Volume
3
Issue
8
Pages
539-547
Publisher
Elsevier
Description
Background
Clinical guidelines advise against pharmacotherapy in bronchiolitis. However, little is known about global variation in prescribing practices for bronchiolitis at discharge from emergency departments. We aimed to evaluate global variation in prescribing practice (ie, inhaled salbutamol, or oral or inhaled corticosteroids) for infants with bronchiolitis at discharge from emergency departments.
Methods
We did a planned secondary analysis of a multinational, retrospective cohort study of the Pediatric Emergency Research Networks. Previously healthy infants (aged <12 months) who were discharged with bronchiolitis between Jan 1 and Dec 31, 2013 from 38 emergency departments in Australia and New Zealand, Canada, Spain and Portugal, the UK and Ireland, and the USA were included. The primary outcome was pharmacotherapy prescription at discharge from the emergency department. Secondary …
Scholar articles
A Jamal, Y Finkelstein, N Kuppermann, SB Freedman… - The Lancet Child & Adolescent Health, 2019